NASDAQ:AMGN - Amgen Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Hold
Consensus Price Target: $242.57
Forecasted Upside: -1.55 %
Number of Analysts: 14
Breakdown:
1 Sell Ratings
10 Hold Ratings
3 Buy Ratings
0 Strong Buy Ratings

^$246.40 As of 07/6/2022 12:16 PM ET

▼ -0.33 (-0.13%)

1 month | 3 months | 12 months

Get New Amgen Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for AMGN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AMGN

^$242.57

▼ -1.55% Downside Potential

This price target is based on 14 analysts offering 12 month price targets for Amgen in the last 3 months. The average price target is $242.57, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a -1.55% upside from the last price of $246.40.

Current Consensus is Hold

The current consensus among 14 contributing investment analysts is to hold stock in Amgen. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
13 buy ratings
16 hold ratings
1 sell ratings

Ratings as of

1/12/2021

0 strong buy ratings
10 buy ratings
14 hold ratings
0 sell ratings

Ratings as of

4/12/2021

0 strong buy ratings
10 buy ratings
13 hold ratings
2 sell ratings

Ratings as of

7/11/2021

0 strong buy ratings
8 buy ratings
12 hold ratings
2 sell ratings

Ratings as of

10/9/2021

0 strong buy ratings
6 buy ratings
11 hold ratings
2 sell ratings

Ratings as of

1/7/2022

0 strong buy ratings
5 buy ratings
11 hold ratings
2 sell ratings

Ratings as of

4/7/2022

0 strong buy ratings
3 buy ratings
10 hold ratings
1 sell ratings

Ratings as of

6/6/2022

0 strong buy ratings
3 buy ratings
10 hold ratings
1 sell ratings

Ratings as of

7/6/2022

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
6/24/2022	Oppenheimer	Reiterated Rating	Outperform ➝ Outperform	$290.00	Low
6/1/2022	Oppenheimer	Boost Price Target	Outperform	$285.00 ➝ $290.00	Medium
5/23/2022	SVB Leerink	Initiated Coverage	Market Perform	$256.00	Low
5/10/2022	Mizuho	Boost Price Target		$202.00 ➝ $208.00	Low
5/3/2022	Oppenheimer	Downgrade	Outperform	$285.00	Low
4/28/2022	BMO Capital Markets	Lower Price Target		$263.00 ➝ $243.00	Low
4/28/2022	Piper Sandler	Boost Price Target		$255.00 ➝ $260.00	High
4/12/2022	Morgan Stanley	Lower Price Target	Equal Weight	$238.00 ➝ $237.00	Low
4/12/2022	Barclays	Boost Price Target	Equal Weight	$233.00 ➝ $236.00	Low
3/1/2022	Mizuho	Boost Price Target		$194.00 ➝ $202.00	Low
2/9/2022	Morgan Stanley	Boost Price Target	Equal Weight	$235.00 ➝ $238.00	Low
2/9/2022	Jefferies Financial Group	Boost Price Target	Buy ➝ Buy	$266.00 ➝ $280.00	Low
2/9/2022	Oppenheimer	Boost Price Target	Outperform	$272.00 ➝ $285.00	Medium
2/9/2022	Barclays	Boost Price Target	Equal Weight	$228.00 ➝ $233.00	Medium
2/9/2022	Wells Fargo & Company	Boost Price Target	Equal Weight	$210.00 ➝ $250.00	Medium
1/5/2022	Bank of America	Downgrade	Buy ➝ Neutral	$285.00 ➝ $255.00	Low
12/21/2021	Royal Bank of Canada	Boost Price Target	Sector Perform	$216.00 ➝ $218.00	Low
12/8/2021	Wells Fargo & Company	Initiated Coverage	Equal Weight	$213.00 ➝ $210.00	Low
12/6/2021	The Goldman Sachs Group	Initiated Coverage	Buy	$258.00	High
11/22/2021	Mizuho	Lower Price Target	Neutral	$222.00 ➝ $194.00	Medium
11/18/2021	BMO Capital Markets	Initiated Coverage	Market Perform	$228.00	Low
11/3/2021	Royal Bank of Canada	Lower Price Target	Sector Perform	$217.00 ➝ $216.00	High
11/3/2021	SVB Leerink	Lower Price Target	Market Perform	$234.00 ➝ $216.00	High
11/3/2021	Barclays	Lower Price Target	Equal Weight	$230.00 ➝ $228.00	High
11/1/2021	Oppenheimer	Lower Price Target	Outperform	$277.00 ➝ $272.00	Medium
10/28/2021	Robert W. Baird	Reiterated Rating	Sell		Low
10/12/2021	Morgan Stanley	Lower Price Target	Equal Weight	$251.00 ➝ $235.00	High
9/23/2021	Daiwa Capital Markets	Downgrade	Outperform ➝ Neutral	$220.00	Low
9/19/2021	SVB Leerink	Initiated Coverage	Hold		Medium
9/17/2021	William Blair	Reiterated Rating	Hold		High
9/10/2021	Mizuho	Initiated Coverage	Hold	$222.00	Low
9/7/2021	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$280.00 ➝ $251.00	High
8/5/2021	Robert W. Baird	Reiterated Rating	Sell		High
8/4/2021	SVB Leerink	Lower Price Target	Market Perform	$238.00 ➝ $234.00	High
7/28/2021	Robert W. Baird	Reiterated Rating	Sell	$185.00	Low
7/16/2021	Morgan Stanley	Boost Price Target	Overweight	$278.00 ➝ $280.00	Medium
6/25/2021	Mizuho	Reiterated Rating	Hold	$200.00	Medium
6/7/2021	SVB Leerink	Boost Price Target	Market Perform	$230.00 ➝ $238.00	Low
6/7/2021	Oppenheimer	Boost Price Target	Outperform	$272.00 ➝ $277.00	Low
5/31/2021	BMO Capital Markets	Boost Price Target	Positive ➝ Outperform	$296.00 ➝ $301.00	High
5/17/2021	Oppenheimer	Reiterated Rating	Buy	$270.00	Low
5/4/2021	Atlantic Securities	Reiterated Rating	Neutral ➝ Underweight	$200.00	N/A
5/3/2021	Oppenheimer	Lower Price Target	Outperform	$275.00 ➝ $265.00	Low
4/29/2021	Robert W. Baird	Reiterated Rating	Sell		Medium
4/29/2021	Evercore ISI	Reiterated Rating	Buy		Medium
4/28/2021	Atlantic Securities	Downgrade	Neutral ➝ Underweight	$200.00	Low
4/28/2021	Credit Suisse Group	Lower Price Target	Outperform	$265.00 ➝ $259.00	High
4/28/2021	SVB Leerink	Lower Price Target	Market Perform	$267.00 ➝ $230.00	High
4/28/2021	Royal Bank of Canada	Lower Price Target	Sector Perform	$220.00 ➝ $217.00	High
4/28/2021	JPMorgan Chase & Co.	Reiterated Rating	Neutral	$215.00	High
4/28/2021	The Goldman Sachs Group	Reiterated Rating	Buy	$290.00	High
4/28/2021	BMO Capital Markets	Lower Price Target	Outperform	$301.00 ➝ $296.00	High
4/26/2021	Morgan Stanley	Lower Price Target	Overweight	$281.00 ➝ $278.00	Low
4/19/2021	Morgan Stanley	Boost Price Target	Overweight	$279.00 ➝ $281.00	Low
4/5/2021	Oppenheimer	Boost Price Target		$266.00 ➝ $275.00	Low
3/5/2021	Barclays	Lower Price Target	Equal Weight	$242.00 ➝ $230.00	High
3/5/2021	Morgan Stanley	Boost Price Target	Overweight	$277.00 ➝ $279.00	High
3/4/2021	JPMorgan Chase & Co.	Set Price Target	Neutral	$222.00	High
3/4/2021	The Goldman Sachs Group	Set Price Target	Buy	$277.00	High
3/1/2021	SVB Leerink	Boost Price Target	Market Perform	$252.00 ➝ $260.00	Low
2/3/2021	Morgan Stanley	Lower Price Target	Overweight	$285.00 ➝ $277.00	Medium
2/3/2021	Credit Suisse Group	Lower Price Target	Outperform	$280.00 ➝ $265.00	Medium
2/3/2021	SVB Leerink	Lower Price Target	Market Perform	$253.00 ➝ $245.00	Medium
2/3/2021	Piper Sandler	Lower Price Target	Overweight	$280.00 ➝ $260.00	Medium
2/3/2021	Cantor Fitzgerald	Boost Price Target	Positive ➝ Overweight	$280.00 ➝ $295.00	Low
1/31/2021	Oppenheimer	Reiterated Rating	Buy	$266.00	Low
1/19/2021	Morgan Stanley	Boost Price Target	Overweight	$276.00 ➝ $285.00	Low
1/4/2021	Royal Bank of Canada	Reiterated Rating	Neutral		N/A
12/29/2020	Daiwa Capital Markets	Initiated Coverage	Buy	$300.00 ➝ $300.00	N/A
12/29/2020	Royal Bank of Canada	Reiterated Rating	Neutral		N/A
12/27/2020	Oppenheimer	Initiated Coverage	Positive ➝ Buy	$274.00 ➝ $266.00	N/A
12/27/2020	JPMorgan Chase & Co.	Reiterated Rating	Hold		N/A
12/23/2020	Royal Bank of Canada	Reiterated Rating	Neutral		N/A
12/16/2020	Morgan Stanley	Boost Price Target	Overweight	$275.00 ➝ $276.00	Low
12/15/2020	The Goldman Sachs Group	Downgrade	Conviction-Buy ➝ Buy		Medium
12/9/2020	SVB Leerink	Boost Price Target	Market Perform	$243.00 ➝ $253.00	Low
12/8/2020	Piper Sandler	Boost Price Target	Overweight	$270.00 ➝ $280.00	Low
11/16/2020	Oppenheimer	Lower Price Target	Outperform	$280.00 ➝ $274.00	Low
11/11/2020	Oppenheimer	Initiated Coverage	Positive ➝ Buy	$275.00 ➝ $280.00	Low
11/2/2020	Mizuho	Lower Price Target	Neutral	$260.00 ➝ $215.00	Low
10/29/2020	Cantor Fitzgerald	Lower Price Target	Overweight	$279.00 ➝ $278.00	Low
10/29/2020	BMO Capital Markets	Lower Price Target	Outperform	$308.00 ➝ $304.00	Low
10/29/2020	JPMorgan Chase & Co.	Lower Price Target	Neutral	$232.00 ➝ $222.00	Medium
10/29/2020	SVB Leerink	Lower Price Target	Market Perform	$261.00 ➝ $243.00	Medium
10/29/2020	Bank of America	Lower Price Target	Buy	$275.00 ➝ $265.00	Medium
10/29/2020	Morgan Stanley	Boost Price Target	Market Perform ➝ Overweight	$273.00 ➝ $275.00	Medium
10/29/2020	Barclays	Lower Price Target	Equal Weight	$250.00 ➝ $242.00	Low
10/28/2020	UBS Group	Initiated Coverage	Neutral	$232.00	High
10/27/2020	Credit Suisse Group	Lower Price Target	Outperform	$286.00 ➝ $284.00	Low
10/26/2020	Raymond James	Upgrade	Market Perform ➝ Outperform	$255.00	Medium
10/22/2020	Oppenheimer	Lower Price Target	Outperform	$280.00 ➝ $275.00	Low
10/15/2020	Royal Bank of Canada	Reiterated Rating	Hold	$223.00	Medium
10/13/2020	Morgan Stanley	Lower Price Target	Overweight	$281.00 ➝ $273.00	Low
10/12/2020	Truist Financial	Upgrade	Hold ➝ Buy		Low
10/9/2020	Truist Financial	Downgrade	Buy ➝ Hold	$251.00	Medium
10/9/2020	Sanford C. Bernstein	Downgrade	Outperform ➝ Market Perform		Medium
10/6/2020	Raymond James	Reiterated Rating	Outperform ➝ Market Perform		Medium
10/6/2020	Oppenheimer	Boost Price Target	Positive ➝ Outperform	$270.00 ➝ $280.00	Medium
9/23/2020	William Blair	Reiterated Rating	Hold		Medium
9/22/2020	JPMorgan Chase & Co.	Reiterated Rating	Hold		High
9/21/2020	Oppenheimer	Reiterated Rating	Buy	$270.00	Medium
7/30/2020	SunTrust Banks	Boost Price Target	Buy	$254.00 ➝ $268.00	Low
7/29/2020	Credit Suisse Group	Reiterated Rating	Buy		Low
7/29/2020	Wells Fargo & Company	Boost Price Target	Equal Weight ➝ In-Line	$237.00 ➝ $247.00	Low
7/29/2020	Jefferies Financial Group	Boost Price Target	Buy	$285.00 ➝ $300.00	Low
7/29/2020	Royal Bank of Canada	Lower Price Target	Sector Perform	$236.00 ➝ $223.00	High
7/29/2020	Morgan Stanley	Lower Price Target	Overweight	$285.00 ➝ $281.00	Medium
7/29/2020	SVB Leerink	Boost Price Target	Market Perform	$253.00 ➝ $261.00	Medium
7/29/2020	Cantor Fitzgerald	Boost Price Target	Overweight	$263.00 ➝ $279.00	Medium
7/29/2020	Barclays	Boost Price Target	Equal Weight	$245.00 ➝ $250.00	Medium
7/28/2020	Piper Sandler	Boost Price Target	Positive ➝ Overweight	$255.00 ➝ $270.00	Medium
7/28/2020	JPMorgan Chase & Co.	Boost Price Target	Neutral	$225.00 ➝ $232.00	Medium
7/20/2020	Oppenheimer	Boost Price Target	Outperform	$252.00 ➝ $265.00	Low
7/20/2020	Credit Suisse Group	Boost Price Target	Outperform	$252.00 ➝ $290.00	Low
7/15/2020	Morgan Stanley	Boost Price Target	Overweight	$280.00 ➝ $285.00	Low
6/18/2020	JPMorgan Chase & Co.	Boost Price Target	Neutral	$219.00 ➝ $225.00	Medium
6/2/2020	SVB Leerink	Boost Price Target	Market Perform	$249.00 ➝ $253.00	High
5/4/2020	Cantor Fitzgerald	Boost Price Target	Overweight	$255.00 ➝ $263.00	Low
5/1/2020	Cfra	Boost Price Target	Buy	$223.00 ➝ $259.00	Low
5/1/2020	Bank of America	Boost Price Target	Buy	$250.00 ➝ $265.00	High
5/1/2020	SVB Leerink	Boost Price Target	Market Perform	$219.00 ➝ $249.00	High
5/1/2020	Morgan Stanley	Boost Price Target	Overweight	$267.00 ➝ $280.00	High
5/1/2020	BMO Capital Markets	Boost Price Target	Positive ➝ Outperform	$274.00 ➝ $291.00	High
5/1/2020	Wells Fargo & Company	Boost Price Target	Equal Weight	$220.00 ➝ $237.00	High
5/1/2020	Oppenheimer	Initiated Coverage	Buy	$252.00	Medium
4/30/2020	Mizuho	Reiterated Rating	Hold	$215.00	Medium
4/30/2020	Piper Sandler	Boost Price Target	Overweight	$235.00 ➝ $255.00	Medium
4/26/2020	Oppenheimer	Boost Price Target	Outperform	$240.00 ➝ $250.00	Medium
4/15/2020	Morgan Stanley	Lower Price Target	Overweight	$277.00 ➝ $267.00	Low
4/15/2020	Guggenheim	Initiated Coverage	Neutral	$225.00	Low
3/31/2020	Wolfe Research	Initiated Coverage	Market Perform	$218.00	Medium
3/29/2020	Raymond James	Upgrade	Market Perform ➝ Outperform	$255.00	High
3/26/2020	Oppenheimer	Lower Price Target	Outperform	$250.00 ➝ $240.00	High
3/13/2020	Cfra	Upgrade	Hold ➝ Buy		High
3/9/2020	Oppenheimer	Lower Price Target		$256.00 ➝ $250.00	Medium
3/5/2020	Bank of America	Upgrade	Neutral ➝ Buy	$245.00 ➝ $250.00	Medium
2/27/2020	Barclays	Initiated Coverage	Equal Weight	$235.00	High
2/6/2020	Argus	Reiterated Rating	Buy	$265.00 ➝ $265.00	Low
2/3/2020	SunTrust Banks	Boost Price Target	Buy ➝ Buy	$254.00 ➝ $265.00	Low
2/2/2020	Credit Suisse Group	Reiterated Rating	Buy	$252.00	Low
2/2/2020	JPMorgan Chase & Co.	Reiterated Rating	Neutral ➝ Hold		Low
1/31/2020	Cfra	Boost Price Target	Hold	$215.00 ➝ $223.00	High
1/31/2020	Cowen	Reiterated Rating	Buy		High
1/31/2020	Robert W. Baird	Downgrade	Neutral ➝ Underperform	$173.00 ➝ $185.00	High
1/30/2020	Mizuho	Reiterated Rating	Hold	$215.00	High
1/24/2020	JPMorgan Chase & Co.	Set Price Target	Neutral	$198.00	Low
1/23/2020	Citigroup	Boost Price Target	Buy ➝ In-Line	$245.00 ➝ $275.00	Low
1/22/2020	UBS Group	Boost Price Target	Neutral	$194.00 ➝ $238.00	Low
1/21/2020	Oppenheimer	Boost Price Target		$250.00 ➝ $260.00	Low
1/21/2020	Evercore ISI	Upgrade	In-Line ➝ Outperform		Medium
1/19/2020	JPMorgan Chase & Co.	Reiterated Rating	Hold		Medium
1/17/2020	Morgan Stanley	Lower Price Target	Overweight	$280.00 ➝ $277.00	Low
1/14/2020	Cantor Fitzgerald	Reiterated Rating	Buy	$255.00	Low
1/9/2020	BMO Capital Markets	Boost Price Target	Outperform	$240.00 ➝ $275.00	Low
12/23/2019	Raymond James	Initiated Coverage	Market Perform		N/A
12/19/2019	Cowen	Boost Price Target	Outperform	$253.00 ➝ $277.00	Medium
12/17/2019	Morgan Stanley	Initiated Coverage	Overweight	$280.00	Low
12/13/2019	Credit Suisse Group	Boost Price Target	Outperform	$235.00 ➝ $250.00	Medium
12/9/2019	Argus	Boost Price Target	Positive ➝ Buy	$240.00 ➝ $265.00	Low
11/12/2019	SunTrust Banks	Initiated Coverage	Buy	$256.00	Low
11/5/2019	Cantor Fitzgerald	Upgrade	Neutral ➝ Overweight	$230.00 ➝ $255.00	Low
10/30/2019	SVB Leerink	Boost Price Target	Market Perform	$189.00 ➝ $205.00	High
10/16/2019	Bank of America	Initiated Coverage	Neutral	$215.00	Low
10/14/2019	Sanford C. Bernstein	Initiated Coverage	Outperform		Low
9/30/2019	JPMorgan Chase & Co.	Reiterated Rating	Hold		Medium
9/30/2019	The Goldman Sachs Group	Set Price Target	Buy	$243.00	Medium
9/30/2019	BMO Capital Markets	Set Price Target	Buy	$240.00	Medium
9/30/2019	Cantor Fitzgerald	Set Price Target	Hold	$230.00	Medium
9/30/2019	SVB Leerink	Set Price Target	Hold	$189.00	Medium
9/30/2019	Royal Bank of Canada	Reiterated Rating	Hold		Medium
9/29/2019	Cowen	Set Price Target	Buy	$231.00	Medium
9/29/2019	Mizuho	Reiterated Rating	Hold	$212.00	Medium
9/12/2019	SVB Leerink	Reiterated Rating	Hold		Low
9/9/2019	BMO Capital Markets	Reiterated Rating	Buy		High
9/9/2019	Oppenheimer	Set Price Target	Buy	$240.00	High
9/6/2019	JPMorgan Chase & Co.	Set Price Target	Hold	$198.00	High
9/5/2019	Cantor Fitzgerald	Reiterated Rating	Neutral	$221.00 ➝ $230.00	Low
8/30/2019	William Blair	Reiterated Rating	Hold		Medium
8/29/2019	JPMorgan Chase & Co.	Boost Price Target	Neutral	$191.00 ➝ $198.00	Low
8/27/2019	Oppenheimer	Boost Price Target		$230.00 ➝ $240.00	Low
8/27/2019	BMO Capital Markets	Boost Price Target	Outperform	$230.00 ➝ $240.00	Low
8/27/2019	JPMorgan Chase & Co.	Reiterated Rating	Hold	$191.00 ➝ $198.00	Low
8/27/2019	Wells Fargo & Company	Reiterated Rating	Market Perform	$202.00 ➝ $220.00	Low
8/27/2019	Royal Bank of Canada	Boost Price Target	Sector Perform	$192.00 ➝ $206.00	Low
8/26/2019	Piper Jaffray Companies	Boost Price Target	Overweight	$210.00 ➝ $218.00	Low
8/22/2019	Cowen	Set Price Target	Buy	$231.00	Low
8/21/2019	Royal Bank of Canada	Boost Price Target	Sector Perform	$192.00	Low
8/19/2019	Mizuho	Downgrade	Buy ➝ Neutral	$208.00 ➝ $212.00	Low
8/16/2019	Credit Suisse Group	Reiterated Rating	Outperform	$202.00 ➝ $225.00	Low
8/13/2019	Oppenheimer	Boost Price Target	Outperform	$210.00 ➝ $230.00	Medium
8/12/2019	Citigroup	Reiterated Rating	Buy		Low
8/12/2019	Credit Suisse Group	Set Price Target	Buy	$202.00	Low
8/12/2019	Wells Fargo & Company	Boost Price Target	Market Perform ➝ Market Perform	$197.00 ➝ $202.00	High
8/11/2019	Evercore ISI	Reiterated Rating	Hold		High
8/11/2019	Royal Bank of Canada	Reiterated Rating	Hold		High
8/10/2019	Piper Jaffray Companies	Set Price Target	Buy	$210.00	Low
8/9/2019	JPMorgan Chase & Co.	Reiterated Rating	Hold		Low
7/31/2019	BMO Capital Markets	Set Price Target	Buy	$230.00	Low
7/15/2019	Morgan Stanley	Lower Price Target	Overweight	$211.00 ➝ $207.00	Low
7/1/2019	Mizuho	Reiterated Rating	Buy	$208.00	Low
6/24/2019	Mizuho	Reiterated Rating	Buy	$208.00	Low
5/24/2019	Oppenheimer	Set Price Target	Buy	$210.00	Medium
5/22/2019	Citigroup	Upgrade	Neutral ➝ Buy	$211.00 ➝ $205.00	Low
5/21/2019	Royal Bank of Canada	Reiterated Rating	Neutral	$192.00	Low
5/20/2019	Credit Suisse Group	Initiated Coverage	Outperform	$208.00 ➝ $208.00	Low
5/17/2019	Mizuho	Reiterated Rating	Buy	$208.00	Low
5/15/2019	JPMorgan Chase & Co.	Reiterated Rating	Hold	$190.00	Medium
5/10/2019	Mizuho	Set Price Target	Buy	$208.00	High
5/1/2019	Cowen	Reiterated Rating	Buy	$229.00	High
4/22/2019	Mizuho	Set Price Target	Buy	$208.00	Low
4/12/2019	Mizuho	Set Price Target	Buy	$208.00	Low
4/1/2019	Cantor Fitzgerald	Reiterated Rating	Hold	$221.00	Low
3/22/2019	Mizuho	Set Price Target	Buy	$208.00	Low
3/14/2019	BMO Capital Markets	Initiated Coverage	Outperform	$228.00	High
2/26/2019	Mizuho	Reiterated Rating	Buy	$211.00	Low
2/26/2019	Cowen	Reiterated Rating	Buy	$234.00	Low
2/13/2019	Mizuho	Reiterated Rating	Buy	$211.00	Low
2/1/2019	Royal Bank of Canada	Reiterated Rating	Neutral		Low
1/30/2019	SVB Leerink	Lower Price Target	Market Perform	$200.00 ➝ $192.00	High
1/30/2019	JPMorgan Chase & Co.	Reiterated Rating	Neutral	$190.00	High
1/27/2019	Oppenheimer	Set Price Target	Buy	$224.00	High
1/17/2019	The Goldman Sachs Group	Reiterated Rating	Buy	$232.00	Low
1/14/2019	Royal Bank of Canada	Reiterated Rating	Neutral	$182.00	Low
1/4/2019	Citigroup	Boost Price Target	Neutral ➝ Neutral	$204.00 ➝ $210.00	Low
12/19/2018	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$213.00 ➝ $212.00	Medium
12/10/2018	The Goldman Sachs Group	Set Price Target	Buy	$232.00	Low
12/4/2018	Jefferies Financial Group	Reiterated Rating	Buy	$220.00	Medium
12/4/2018	Barclays	Reiterated Rating	Neutral	$195.00	Medium
12/4/2018	Cantor Fitzgerald	Reiterated Rating	Neutral	$223.00	Medium
12/4/2018	JPMorgan Chase & Co.	Set Price Target	Neutral	$192.00	Medium
12/4/2018	Royal Bank of Canada	Reiterated Rating	Neutral	$182.00	Medium
12/4/2018	Morgan Stanley	Reiterated Rating	Buy	$213.00	Medium
12/4/2018	The Goldman Sachs Group	Reiterated Rating	Buy	$232.00	Medium
11/1/2018	Royal Bank of Canada	Reiterated Rating	Neutral		Low
11/1/2018	Citigroup	Boost Price Target	Neutral ➝ Neutral	$200.00 ➝ $204.00	Low
10/31/2018	The Goldman Sachs Group	Reiterated Rating	Buy	$221.00	Low
10/31/2018	Morgan Stanley	Boost Price Target	Overweight ➝ Buy	$212.00 ➝ $213.00	Low
10/31/2018	Royal Bank of Canada	Lower Price Target	Market Perform	$182.00	Low
10/31/2018	Cantor Fitzgerald	Reiterated Rating	Hold	$223.00	Medium
10/30/2018	Oppenheimer	Set Price Target	Buy	$224.00	Medium
10/26/2018	Mizuho	Reiterated Rating	Buy	$206.00	Low
10/25/2018	JPMorgan Chase & Co.	Reiterated Rating	Neutral		Low
10/12/2018	The Goldman Sachs Group	Reiterated Rating	Buy	$229.00	Low
10/11/2018	Morgan Stanley	Boost Price Target	Overweight	$210.00 ➝ $212.00	Low
10/9/2018	JPMorgan Chase & Co.	Set Price Target	Neutral	$192.00	Low
10/8/2018	Cantor Fitzgerald	Set Price Target	Neutral	$223.00	Low
10/8/2018	Jefferies Financial Group	Set Price Target	Buy	$220.00	Low
10/2/2018	Oppenheimer	Reiterated Rating	Buy	$224.00	Low
10/1/2018	Jefferies Financial Group	Reiterated Rating	Buy	$220.00	Medium
10/1/2018	Cantor Fitzgerald	Initiated Coverage	Neutral ➝ Neutral	$223.00	Low
9/28/2018	Royal Bank of Canada	Set Price Target	Neutral	$193.00	Low
9/17/2018	SVB Leerink	Set Price Target	Hold	$209.00	Low
9/12/2018	Jefferies Financial Group	Set Price Target	Buy	$220.00	Low
9/10/2018	Oppenheimer	Set Price Target	Buy	$224.00	High
9/10/2018	Royal Bank of Canada	Reiterated Rating	Neutral	$193.00	High
9/6/2018	Jefferies Financial Group	Set Price Target	Buy	$220.00	Low
8/29/2018	Wells Fargo & Company	Reiterated Rating	Neutral	$197.00	Medium
8/28/2018	Oppenheimer	Reiterated Rating	Buy	$224.00	Low
8/24/2018	Jefferies Financial Group	Reiterated Rating	Buy	$220.00	Low
7/30/2018	Morningstar	Set Price Target	Neutral	$198.00	Low
7/30/2018	Wells Fargo & Company	Reiterated Rating	Neutral	$197.00	Low
7/30/2018	Oppenheimer	Reiterated Rating	Buy	$224.00	Low
7/30/2018	Robert W. Baird	Boost Price Target	Neutral ➝ Neutral	$165.00 ➝ $179.00	Low
7/30/2018	Citigroup	Boost Price Target	Neutral ➝ Neutral	$188.00 ➝ $200.00	Low
7/27/2018	Mizuho	Reiterated Rating	Buy	$200.00	Low
7/27/2018	The Goldman Sachs Group	Reiterated Rating	Buy	$228.00	Low
7/27/2018	Royal Bank of Canada	Set Price Target	Buy	$193.00	Low
7/27/2018	Jefferies Financial Group	Boost Price Target	Buy ➝ Buy	$200.00 ➝ $220.00	High
7/27/2018	JPMorgan Chase & Co.	Boost Price Target	Neutral ➝ Neutral	$191.00 ➝ $192.00	High
7/26/2018	Piper Jaffray Companies	Boost Price Target	In-Line ➝ Overweight	$190.00 ➝ $210.00	High
7/16/2018	Jefferies Financial Group	Reiterated Rating	Buy	$200.00	Low
7/13/2018	Morgan Stanley	Boost Price Target	Buy	$200.00 ➝ $210.00	Low
6/22/2018	Mizuho	Reiterated Rating	Buy	$200.00	Low
5/15/2018	Mizuho	Set Price Target	Buy	$200.00	High
4/25/2018	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$205.00 ➝ $200.00	Medium
4/25/2018	Royal Bank of Canada	Lower Price Target	Sector Perform	$183.00	High
4/24/2018	Mizuho	Set Price Target	Buy	$200.00	High
4/24/2018	Cowen	Reiterated Rating	Buy	$204.00	Medium
4/5/2018	Barclays	Lower Price Target	Equal Weight ➝ Equal Weight	$190.00 ➝ $180.00	Low
2/12/2018	Mizuho	Boost Price Target	Buy ➝ Buy	$192.00 ➝ $200.00	Low
2/5/2018	Atlantic Securities	Downgrade	Overweight ➝ Neutral	$187.01	High
2/4/2018	JPMorgan Chase & Co.	Reiterated Rating	Hold	$191.00	High
2/2/2018	SVB Leerink	Reiterated Rating	Market Perform		High
2/2/2018	Cowen	Reiterated Rating	Buy	$204.00	Low
2/2/2018	Credit Suisse Group	Boost Price Target	Neutral ➝ Neutral	$191.00 ➝ $194.00	Low
2/2/2018	BMO Capital Markets	Boost Price Target	Market Perform ➝ Market Perform	$192.00 ➝ $202.00	Medium
2/2/2018	Morgan Stanley	Lower Price Target	Overweight ➝ Overweight	$204.00 ➝ $196.00	Medium
2/2/2018	Piper Jaffray Companies	Lower Price Target	Overweight ➝ Overweight	$194.00 ➝ $190.00	Medium
2/1/2018	Mizuho	Reiterated Rating	Buy	$192.00	High
1/30/2018	Oppenheimer	Reiterated Rating	Buy	$205.00 ➝ $205.00	Low
1/24/2018	JPMorgan Chase & Co.	Boost Price Target	Neutral ➝ Neutral	$184.00 ➝ $189.00	Low
1/24/2018	Royal Bank of Canada	Reiterated Rating	Hold	$189.00	Low
1/23/2018	Argus	Upgrade	Hold ➝ Buy	$192.33 ➝ $220.00	Low
1/5/2018	Oppenheimer	Set Price Target	Buy	$205.00	Low
1/2/2018	Piper Jaffray Companies	Reiterated Rating	Buy		Low
12/28/2017	Mizuho	Set Price Target	Buy	$192.00	Low
12/22/2017	Mizuho	Set Price Target	Buy	$192.00	Low
12/18/2017	Citigroup	Downgrade	Neutral		Low
12/15/2017	The Goldman Sachs Group	Downgrade	Conviction-Buy ➝ Buy		High
12/12/2017	Oppenheimer	Set Price Target	Buy	$205.00	Low
11/30/2017	Oppenheimer	Reiterated Rating	Buy	$205.00	Low
11/1/2017	Argus	Downgrade	Buy ➝ Hold	$175.22 ➝ $195.00	N/A
10/29/2017	Mizuho	Set Price Target	Buy	$198.00	N/A
10/26/2017	BMO Capital Markets	Reiterated Rating	Market Perform	$198.00	N/A
10/26/2017	Morgan Stanley	Lower Price Target	Overweight	$196.00 ➝ $193.00	N/A
10/26/2017	Royal Bank of Canada	Lower Price Target	Sector Perform	$192.00 ➝ $188.00	N/A
10/20/2017	BMO Capital Markets	Reiterated Rating	Hold	$198.00	N/A
10/13/2017	Barclays	Boost Price Target	Equal Weight	$180.00 ➝ $190.00	N/A
10/6/2017	Oppenheimer	Reiterated Rating	Buy	$203.00	N/A
10/6/2017	Mizuho	Reiterated Rating	Buy	$198.00	N/A
10/6/2017	Morgan Stanley	Reiterated Rating	Overweight	$189.00 ➝ $196.00	N/A
10/5/2017	Bank of America	Boost Price Target	Buy	$210.00	N/A
9/29/2017	Credit Suisse Group	Reiterated Rating	Neutral	$177.00 ➝ $186.00	Medium
9/28/2017	Mizuho	Reiterated Rating	Buy ➝ Buy	$183.00 ➝ $198.00	Low
9/25/2017	Jefferies Financial Group	Reiterated Rating	Buy	$200.00	Low
9/25/2017	BMO Capital Markets	Reiterated Rating	Hold	$199.00	Low
9/14/2017	Royal Bank of Canada	Initiated Coverage	Sector Perform ➝ Sector Perform	$192.00	High
9/7/2017	Oppenheimer	Reiterated Rating	Buy	$203.00	Low
8/21/2017	Mizuho	Reiterated Rating	Buy	$195.00 ➝ $183.00	Low
7/27/2017	Argus	Boost Price Target	Buy	$180.00 ➝ $195.00	Low
7/26/2017	UBS Group	Set Price Target	Hold	$175.00 ➝ $180.00	High
7/26/2017	Oppenheimer	Reiterated Rating	Outperform	$189.00 ➝ $203.00	Low
7/26/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Hold	$172.00 ➝ $174.00	Low
7/26/2017	BMO Capital Markets	Downgrade	Outperform ➝ Market Perform		Low
7/22/2017	Cowen	Reiterated Rating	Outperform	$209.00	Low
7/21/2017	BMO Capital Markets	Downgrade	Outperform ➝ Market Perform	$199.00	Low
7/17/2017	Jefferies Financial Group	Reiterated Rating	Buy	$195.00	Low
7/14/2017	Credit Suisse Group	Set Price Target	Hold	$177.00	Low
7/14/2017	Oppenheimer	Reiterated Rating	Outperform	$189.00	Low
7/11/2017	Jefferies Financial Group	Reiterated Rating	Buy ➝ Buy	$195.00	Low
7/10/2017	Morgan Stanley	Reiterated Rating	Overweight		Low
7/9/2017	Mizuho	Reiterated Rating	Buy	$195.00	Low

(Data available from 7/6/2017 forward)

News Sentiment Rating

0.23 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

19 very positive mentions
41 positive mentions
4 negative mentions
2 very negative mentions

Mentions as of

12/8/2021

9 very positive mentions
43 positive mentions
3 negative mentions
3 very negative mentions

Mentions as of

1/7/2022

14 very positive mentions
40 positive mentions
5 negative mentions
4 very negative mentions

Mentions as of

2/6/2022

19 very positive mentions
30 positive mentions
5 negative mentions
2 very negative mentions

Mentions as of

3/8/2022

9 very positive mentions
26 positive mentions
2 negative mentions
2 very negative mentions

Mentions as of

4/7/2022

12 very positive mentions
45 positive mentions
3 negative mentions
6 very negative mentions

Mentions as of

5/7/2022

13 very positive mentions
26 positive mentions
2 negative mentions
0 very negative mentions

Mentions as of

6/6/2022

9 very positive mentions
28 positive mentions
7 negative mentions
1 very negative mentions

Mentions as of

7/6/2022

Current Sentiment

Recent Stories by Sentiment

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Today's Range

Now: $246.40

$245.88

$248.06

50 Day Range

MA: $243.16

$230.71

$256.74

52 Week Range

Now: $246.40

$198.64

$258.45

Volume

40,114 shs

Average Volume

3,391,541 shs

Market Capitalization

$131.63 billion

P/E Ratio

24.28

Dividend Yield

3.16%

Beta

0.58

Frequently Asked Questions

What sell-side analysts currently cover shares of Amgen?: The following Wall Street research analysts have issued reports on Amgen in the last year: Bank of America Co., Barclays PLC, BMO Capital Markets, Daiwa Capital Markets, Jefferies Financial Group Inc., Mizuho, Morgan Stanley, Oppenheimer Holdings Inc., Piper Sandler, Robert W. Baird, Royal Bank of Canada, StockNews.com, SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, Wells Fargo & Company, and William Blair.
View the latest analyst ratings for AMGN.
What is the current price target for Amgen?: 0 Wall Street analysts have set twelve-month price targets for Amgen in the last year. Their average twelve-month price target is $242.57, suggesting a possible downside of 1.7%.
View the latest price targets for AMGN.
What is the current consensus analyst rating for Amgen?: Amgen currently has 1 sell rating, 10 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in AMGN, but not buy more shares or sell existing shares.
View the latest ratings for AMGN.
What other companies compete with Amgen?: Other companies that are similar to Amgen include Gilead Sciences, Vertex Pharmaceuticals, Regeneron Pharmaceuticals, Seagen, Biogen, Alnylam Pharmaceuticals, Incyte, BioMarin Pharmaceutical, United Therapeutics, Neurocrine Biosciences, Repligen, Exact Sciences, Exelixis, Halozyme Therapeutics and Ionis Pharmaceuticals. Learn More about companies similar to Amgen.
How do I contact Amgen's investor relations team?: Amgen's physical mailing address is ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA, 91320. The medical research company's listed phone number is (805) 447-1000 and its investor relations email address is [email protected] The official website for Amgen is www.amgen.com. Learn More about contacing Amgen investor relations.

NASDAQ:AMGN - Amgen Stock Price Target and Predictions

Analyst Price Target for AMGN

Current Consensus is Hold

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.23 (Hold)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Amgen?

What is the current price target for Amgen?

What is the current consensus analyst rating for Amgen?

What other companies compete with Amgen?

How do I contact Amgen's investor relations team?